98%
921
2 minutes
20
Importance: There is a dearth of surgical performance measures that accurately predict long-term patient outcomes.
Objective: To develop surgical performance measures collected at the time of surgery that accurately predict future outcomes.
Design, Setting, And Participants: In this cohort study, surgical video of 157 patients undergoing robotic-assisted radical prostatectomy by 28 surgeons from 4 tertiary referral hospitals across the US and 1 hospital in Germany was analyzed. Four trained and blinded raters annotated video clips of the bilateral nerve-sparing step using standardized tools for identifying surgical gestures and assessing technical skills. Patients were prospectively enrolled from July 2016 to January 2023 and followed up for 12 months postoperatively. Data were analyzed from April to August 2024. Patients with clinically localized prostate cancer undergoing robotic-assisted radical prostatectomy were eligible. Inclusion criteria included adequate erectile function prior to surgery and access to complete surgical video.
Interventions/exposures: Robotic-assisted radical prostatectomy.
Main Outcomes And Measures: Performance metrics were compared between patients who recovered erectile function and those who did not. Erectile function recovery was defined as achieving erections sufficient for intercourse measured using the Sexual Health Inventory for Men.
Results: Fifty-three patients (34%) recovered erectile function at 12 months after surgery. The median age was 64 (IQR, 59-68) years and median body mass index was 28 (IQR, 26-30). In total, 80 957 surgical gestures were annotated and 2568 technical skills scores were evaluated. The impact of performance factors on erectile function recovery was evaluated using univariate logistic regression. Recovery was associated with a greater proportion of peel/push gestures (odds ratio [OR], 1.72; 95% CI, 1.24-2.42, per 0.1 increase; P = .001), lower proportion of energy gestures applied to the neurovascular bundle (OR, 0.35; 95% CI, 0.13-0.81, per 0.1 increase; P = .03), and less gestures grabbing the neurovascular bundle (OR, 0.02; 95% CI, 0.00-0.47, per 0.1 increase; P = .02). Erectile function recovery was associated with higher tissue handling skill scores (OR, 3.43; 95% CI, 1.23-10.90, P = .03). On multivariable regression the association between peel/push gestures and erectile function recovery remained significant (OR, 1.66; 95% CI, 1.18-2.39, per 0.1 increase; P = .005).
Conclusions And Relevance: Surgical performance can be assessed from data collected during surgery and used to predict erectile function 12 months later. This was not previously feasible due to a lack of quantitative methods for assessing surgical performance. Combining surgical gestures and skills assessment demonstrates a novel opportunity for advancing surgical performance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12044537 | PMC |
http://dx.doi.org/10.1001/jamasurg.2025.0931 | DOI Listing |
Am J Physiol Regul Integr Comp Physiol
September 2025
Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL, USA.
Cystathionine γ-lyase (CSE) produces hydrogen sulfide (HS), a vasodilator critical for vascular function. While its systemic effects are well-documented, its role in erectile physiology remains unclear. This study investigated the impact of CSE deletion on vascular and erectile tissue reactivity.
View Article and Find Full Text PDFFront Reprod Health
August 2025
Department of Medical Laboratory Science, Afe Babalola University, Ado-Ekiti, Nigeria.
Background: Vitamin D, sometimes referred to as the "sunshine vitamin", is well-known for its role in maintaining bone health processes that are highly dependent on calcium regulation. However, there is an emerging wealth of evidence that this fat-soluble vitamin has an important role in male sexual health regarding erectile function, production of testosterone, and overall fertility. Due to the increased vitamin D deficiency rates in most populations, the implications of its deficiency on male sexual functions have gained great interest.
View Article and Find Full Text PDFFr J Urol
September 2025
Department of urology, Maison de Santé Protestante de Bordeaux-Bagatelle, Talence, France; Department of urology, HIA Robert-Picqué, Villenave d'Ornon, France.
Objectives: To evaluate the efficacy and safety of oral phosphodiesterase-5 inhibitors (PDE5Is) in the treatment of erectile dysfunction (ED). Additionally, to compare various PDE5Is and assess their suitability for different patient populations.
Evidence Acquisition: A systematic review of literature published from January 1999 to January 2023 was conducted following the PICOS criteria.
Urol J
September 2025
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Purpose: Men with lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH) often experience erectile dysfunction (ED). While transurethral resection of the prostate (TURP) can improve ED, new-onset ED remains a concern. This study compares monopolar (M-TURP) and bipolar (B-TURP) techniques, with a subgroup analysis based on phosphodiesterase-5 inhibitor (PDE5i) use.
View Article and Find Full Text PDFAnn Vasc Surg
September 2025
CETI, 8 rue de Duras, 75008 Paris, France.
Objective: Assess results of simultaneous ligation and embolization for caverno-venous leakage (CVL) in patients with erectile dysfunction (ED) resistant to 5-Phosphodiesterase inhibitors.
Patients And Methods: Data from consecutive patients with ED operated-on for CVL, were collected prospectively. CVLs were diagnosed by Pharmacologicaly-Challenged Penile Duplex Sonography (PC-PDS) and computed tomography cavernosography.